Comparing Maternal and Neonatal Infectious Morbidity in Women With Meconium-Stained Amniotic Fluid Treated With Prophylactic Antibiotics Zinacef Versus Placebo at Term
Led by Western Galilee Hospital-Nahariya · Updated on 2026-09-15
182
Participants Needed
1
Research Sites
52 weeks
Total Duration
AI-Summary
What This Trial Is About
Researchers are studying women with meconium-stained amniotic fluid at term to compare maternal and newborn infection rates between those treated with prophylactic antibiotics zinacef and those given a placebo. This randomized controlled double-blind trial aims to better understand how meconium staining relates to infections such as chorioamnionitis and neonatal sepsis, and to assess the types of bacteria present in infected cases.
Participants are assigned to one of two groups one receives zinacef antibiotic treatment at 750 mg three times daily, while the other receives a placebo consisting of intravenous saline in the same volume and frequency. This study evaluates the effects of these treatments during labor and shortly after birth.
During the trial, women and their newborns will be monitored for infections occurring within seven days around delivery. Researchers will track fever during labor and up to two hours postpartum, antibiotic use in newborns, and neonatal intensive care admissions within one week. This monitoring helps assess the safety and infection outcomes related to the treatments. Participation lasts through labor and up to one week postpartum with close observation.
CONDITIONS
Brief Title
Comparing Infectious Morbidity Among Women With Meconium-stained Amniotic Fluid at Term, Between Those Treated With Prophylactic Antibiotics Zinacef vs. Placebo
Research Team
M
Maya Frank Wolf, prof.
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match. Sign up to get personalized trial recommendations delivered to your inbox.
Participants are screened for eligibility to participate in the trial.
Treatment
Duration - During labor and up to 2 hours postpartum
Participants receive either the antibiotic zinacef or a placebo saline treatment during labor.
Multiple visits during labor and delivery
Follow-up
Duration - 7 days postpartum
Participants and their newborns are monitored for infections and other outcomes up to 7 days after delivery.
Regular assessments during the first week after birth
How is the study designed?
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Similar Trials
Study of Amniotic Fluids Role in Preterm Infant Gut Development and Microbial Growth
Comparing Maternal and Neonatal Infectious Morbidity in Women With Meconium-Stained Amniotic Fluid Treated With Prophylactic Antibiotics Zinacef Versus Placebo at Term
Have more questions? Get in touch with our team for quick support
Published Research Related To This Trial
Prevalence of meconium stained amniotic fluid and its associated factors among women who gave birth at term in Felege Hiwot comprehensive specialized referral hospital, North West Ethiopia: a facility based cross-sectional study.